Biomerica, Inc.
BMRA
Last
$1.84
Day
-0.5%
1y
-35.9%
5y
-95.8%
52w
-41.2%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-10-133d
EMA 21
2.16
EMA 50
2.09
EMA 200
2.20
20d high
-33.5%
5y high
-96.8%
5y range
1th
Positions held
Your positionsBMRA isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
4
Hold
watch
Signal
Neutral
Target
$2.17
Stop
$1.66
Stop distance
9.8%
Target vs last
+17.9%
Fundamentals
| Market cap | $8.69M | Enterprise value | $9.75M | Trailing P/E | — | Forward P/E | 4.85 |
| PEG | — | Price / book | 2.30 | Beta | 0.38 | Dividend yield | 0.00% |
| Revenue growth | 16.8% | Earnings growth | — | Gross margin | 8.1% | Operating margin | -1.8% |
| Profit margin | -84.8% | ROE | -112.1% | ROA | -52.3% | Debt / equity | 0.91 |
| Current ratio | 1.62 | Free cash flow | -$2.30M | Analyst recommendation | none | Mean target | — |
| 52w high | $3.21 | 52w low | $1.45 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.9M | $1.0M | $1.2M | $1.4M | $0.7M | — |
| Op margin | -175.2% | -131.5% | -113.5% | -81.0% | -208.8% | — |
| Net income | -$1.1M | -$1.3M | -$1.3M | $0.0M | -$1.5M | — |
| Gross margin | -8.1% | -4.5% | 4.2% | 30.7% | -32.6% | — |
| Gross profit | -$0.1M | -$0.0M | $0.1M | $0.4M | -$0.2M | — |
| Operating income | -$1.5M | -$1.3M | -$1.4M | -$1.1M | -$1.6M | — |
- Revenue -11% vs prior quarter ($0.9M vs $1.0M).
- Gross margin -8.1% (was -4.5% prior quarter).
- Operating margin compressed to -175.2%.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $4.5M | $5.3M | $5.4M | $5.3M | — |
| Op margin | -119.5% | -96.7% | -117.6% | -135.3% | — |
| Net income | -$3.8M | -$5.0M | -$6.0M | -$7.1M | — |
| Gross margin | 8.1% | 9.4% | 11.3% | 8.4% | — |
| Gross profit | $0.4M | $0.5M | $0.6M | $0.4M | — |
| Operating income | -$5.3M | -$5.1M | -$6.4M | -$7.2M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-25 · Biomerica Files $250 Million Mixed Shelf
2026-09-01 · Biomerica Reports Fiscal 2026 Year-End Financial Results
2026-08-27 · Biomerica Announces $2.23 Million Financing
Price (daily)
Full chart · RSI · MACD · patternsBMRA · daily-27.3% over 14 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin